HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 18, 2024 | $50,000 | Replaced |
| 2nd Quarter - Amendment | Jul 18, 2024 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DAVID PORE | Legislative Director, Cong. Jim Turner |
| THERESA REED | — |
| MICHAEL TOMBERLIN | Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert |
Pharmacy PHA
Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations HR167, the Patient Access to Urgent Use Compounded Medication Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DAVID PORE | Legislative Director, Cong. Jim Turner |
| THERESA REED | — |
| MICHAEL TOMBERLIN | Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.